BFRI 1 (-3.85%)
US09077D1000Drug ManufacturersDrug Manufacturers - Specialty & Generic

Biofrontera (BFRI) Competitor Comparison

We are evaluating the key criteria listed to compare Biofrontera (BFRI) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 3 years - BFRI ranking 49 / 54

These are the competitors of Biofrontera in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 3 years
1. ProPhase Labs PRPH
121.47
2. Zoetis ZTS
65.31
3. Supernus Pharmaceuticals SUPN
23.78
4. Kamada KMDA
17.46
5. Kolinpharma KIP.MI
11.59
6. Evolus EOLS
8.78
7. Regencell Bioscience Holdings RGC
8.64
8. Vifor Pharma G2AB.F
6.24
9. Amneal Pharmaceuticals AMRX
5.49
10. Ironwood Pharmaceuticals IRWD
5.05
11. Perrigo PRGO
4.78
12. Catalent CTLT
4.31
13. Cumberland Pharmaceuticals CPIX
4.25
14. Pacira BioSciences PCRX
4.1
15. Alvotech ALVO
3.98
16. Phibro Animal Health PAHC
3.96
17. Taro Pharmaceutical Industries TARO
3.85
18. Elanco Animal Health ELAN
3.31
19. Linc LNC
3.28
20. Collegium Pharmaceutical COLL
3.12
21. PetIQ PETQ
3.09
22. Zynerba Pharmaceuticals ZYNE
3
23. Eagle Pharmaceuticals EGRX
2.8
24. Green Thumb Industries R9U2.F
2.78
25. Procaps Group PROC
2.73
26. OptiNose OPTN
2.55
27. Embecta EMBC
2.55
28. Societal CDMO SCTL
2.41
29. Alimera Sciences ALIM
2.24
30. Curaleaf Holdings CURLF
2.21
31. SCYNEXIS SCYX
2.18
32. Journey Medical DERM
2.17
33. Amphastar Pharmaceuticals AMPH
2.11
34. Bausch Health Companies BHC
2.1
35. Cronos Group CRON
2.1
36. Theratechnologies THTX
2.08
37. Relmada Therapeutics RLMD
1.97
38. Teva Pharmaceutical Industries TEVA
1.97
39. ANI Pharmaceuticals ANIP
1.9
40. Organogenesis Holdings ORGO
1.86
41. Jupiter Wellness JUPW
1.84
42. Universe Pharmaceuticals UPC
1.84
43. Flora Growth FLGC
1.82
44. Emergent BioSolutions EBS
1.8
45. Clever Leaves Holdings CLVR
1.78
46. Ascend Wellness Holdings AAWH
1.76
47. Alpha Teknova TKNO
1.73
48. Harrow Health HROW
1.71
49. Biofrontera BFRI
1.69
50. Solid Biosciences SLDB
1.63
51. Ayr Wellness 3KJB.F
1.61
52. Tilray Brands TLRY
1.59
53. Neoleukin Therapeutics NLTX
1.57
54. Avadel Pharmaceuticals AVDL
1.4

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.